D-0331-2021 Class III Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0331-2021 was initiated by Teligent Pharma, Inc. on Mar 29, 2021 and is designated Class III. Reason for recall: Failed Stability Specifications: product did not meet viscosity results. The recall status is terminated (terminated Jul 3, 2024). Affected quantity: 62,040 tubes.

Recall details

Product Type
Drugs
Report Date
Apr 21, 2021
Initiation Date
Mar 29, 2021
Termination Date
Jul 3, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
62,040 tubes

Product description

Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.

Reason for recall

Failed Stability Specifications: product did not meet viscosity results.

Distribution pattern

Nationwide in the USA

Code information

Lot 13269, Exp March 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0331-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0331-2021. Report a data issue: hello@regdatalab.com.